# SHF Holdings, Inc.: financial statements, quarterly

SHFS · Nasdaq · CIK 1854963 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/shfs.md) · [Financials](/companies/shfs/financials.md) · [Filings](/companies/shfs/filings.md) · [Insiders](/companies/shfs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/shfs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.3](/filings/0001493152-24-044750.md) | [4.5 d](/filings/0001641172-25-003608.md) | [4.1](/filings/0001641172-25-024207.md) | [4.0](/filings/0001641172-25-024215.md) | [3.5](/filings/0001493152-25-021644.md) | [3.7 d](/filings/0001493152-26-016778.md) | [1.9](/filings/0001493152-26-023748.md) | [1.8](/filings/0001493152-26-036606.md) | [1.8](/filings/0001493152-25-021644.md) | [2.1 d](/filings/0001493152-26-016778.md) | [2.0](/filings/0001493152-26-023748.md) | [1.9](/filings/0001493152-26-036606.md) |
| Operating income | $m | [0.5](/filings/0001493152-24-044750.md) | [(1.7) d](/filings/0001641172-25-003608.md) | [0.3](/filings/0001641172-25-024207.md) | [0.3](/filings/0001641172-25-024215.md) | [0.2](/filings/0001493152-25-021644.md) | [(7.9) d](/filings/0001493152-26-016778.md) | [(2.0)](/filings/0001493152-26-023748.md) | [(1.0)](/filings/0001493152-26-036606.md) | [(1.2)](/filings/0001493152-25-021644.md) | [(1.2) d](/filings/0001493152-26-016778.md) | [(1.8)](/filings/0001493152-26-023748.md) | [(1.0)](/filings/0001493152-26-036606.md) |
| Interest expense | $m | [0.4](/filings/0001493152-23-041096.md) | [(0.4) d](/filings/0001493152-24-012360.md) | [0.2](/filings/0001493152-24-018878.md) | [0.2](/filings/0001641172-25-024215.md) | [0.2](/filings/0001493152-25-021644.md) | [0.0 d](/filings/0001493152-26-016778.md) | [0.1](/filings/0001493152-26-023748.md) | [0.1](/filings/0001641172-25-024215.md) | [0.3](/filings/0001493152-25-021644.md) | [0.0 d](/filings/0001493152-26-016778.md) | [0.0](/filings/0001493152-26-023748.md) | not reported |
| Income tax | $m | [0.1](/filings/0001493152-24-044750.md) | [(0.6) d](/filings/0001641172-25-003608.md) | [(0.4)](/filings/0001641172-25-024207.md) | [0.5](/filings/0001641172-25-024215.md) | [0.0](/filings/0001493152-25-021644.md) | [43.8 d](/filings/0001493152-26-016778.md) | not reported | [(0.1)](/filings/0001493152-26-036606.md) | [0.0 d](/filings/0001493152-25-021644.md) | [0.0 d](/filings/0001493152-26-016778.md) | not reported | not reported |
| Net income | $m | [(0.7)](/filings/0001493152-24-044750.md) | [2.5 d](/filings/0001641172-25-003608.md) | [2.0](/filings/0001641172-25-024207.md) | [0.9](/filings/0001641172-25-024215.md) | [0.4](/filings/0001493152-25-021644.md) | [(51.7) d](/filings/0001493152-26-016778.md) | [(0.8)](/filings/0001493152-26-023748.md) | [(0.9)](/filings/0001493152-26-036606.md) | [0.2](/filings/0001493152-25-021644.md) | [(0.6) d](/filings/0001493152-26-016778.md) | [(1.8)](/filings/0001493152-26-023748.md) | [(1.5)](/filings/0001493152-26-036606.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001493152-24-044750.md) | not reported | [0.73](/filings/0001641172-25-024207.md) | [0.33](/filings/0001641172-25-024215.md) | [0.13](/filings/0001493152-25-021644.md) | not reported | [(0.30)](/filings/0001493152-26-023748.md) | [(0.33)](/filings/0001493152-26-036606.md) | [0.06](/filings/0001493152-25-021644.md) | not reported | [(0.43)](/filings/0001493152-26-023748.md) | [(0.36)](/filings/0001493152-26-036606.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0001493152-24-044750.md) | not reported | [0.74](/filings/0001641172-25-024207.md) | [0.34](/filings/0001641172-25-024215.md) | [0.13](/filings/0001493152-25-021644.md) | not reported | [(0.30)](/filings/0001493152-26-023748.md) | [(0.33)](/filings/0001493152-26-036606.md) | [0.06](/filings/0001493152-25-021644.md) | not reported | [(0.43)](/filings/0001493152-26-023748.md) | [(0.36)](/filings/0001493152-26-036606.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.9](/filings/0001493152-23-041096.md) | [4.9](/filings/0001641172-25-003608.md) | [5.6](/filings/0001493152-24-018878.md) | [6.1](/filings/0001493152-24-032185.md) | [5.9](/filings/0001493152-24-044750.md) | [2.3](/filings/0001493152-26-016778.md) | [0.9](/filings/0001641172-25-024207.md) | [0.2](/filings/0001641172-25-024215.md) | [0.9](/filings/0001493152-25-021644.md) | [6.8](/filings/0001493152-26-036606.md) | [5.9](/filings/0001493152-26-023748.md) | [5.7](/filings/0001493152-26-036606.md) |
| Current assets | $m | [10.6](/filings/0001493152-23-041096.md) | [7.8](/filings/0001641172-25-003608.md) | [7.4](/filings/0001493152-24-018878.md) | [7.8](/filings/0001493152-24-032185.md) | [12.2](/filings/0001493152-24-044750.md) | [11.7](/filings/0001493152-26-016778.md) | [5.2](/filings/0001641172-25-024207.md) | [5.0](/filings/0001641172-25-024215.md) | [11.1](/filings/0001493152-25-021644.md) | [12.2](/filings/0001493152-26-036606.md) | [12.4](/filings/0001493152-26-023748.md) | [10.9](/filings/0001493152-26-036606.md) |
| Total assets | $m | [72.4](/filings/0001493152-23-041096.md) | [67.9](/filings/0001641172-25-003608.md) | [67.7](/filings/0001493152-24-018878.md) | [67.3](/filings/0001493152-24-032185.md) | [66.9](/filings/0001493152-24-044750.md) | [13.2](/filings/0001493152-26-016778.md) | [6.7](/filings/0001641172-25-024207.md) | [6.0](/filings/0001641172-25-024215.md) | [13.7](/filings/0001493152-25-021644.md) | [17.2](/filings/0001493152-26-036606.md) | [15.7](/filings/0001493152-26-023748.md) | [14.2](/filings/0001493152-26-036606.md) |
| Current liabilities | $m | [20.0](/filings/0001493152-23-041096.md) | [7.9](/filings/0001641172-25-003608.md) | [7.1](/filings/0001493152-24-018878.md) | [7.5](/filings/0001493152-24-032185.md) | [14.7](/filings/0001493152-24-044750.md) | [12.7](/filings/0001493152-26-016778.md) | [11.9](/filings/0001641172-25-024207.md) | [12.3](/filings/0001641172-25-024215.md) | [5.3](/filings/0001493152-25-021644.md) | [6.5](/filings/0001493152-26-036606.md) | [6.9](/filings/0001493152-26-023748.md) | [6.2](/filings/0001493152-26-036606.md) |
| Total liabilities | $m | [45.4](/filings/0001493152-23-041096.md) | [33.5](/filings/0001641172-25-003608.md) | [30.7](/filings/0001493152-24-018878.md) | [28.9](/filings/0001493152-24-032185.md) | [27.5](/filings/0001493152-24-044750.md) | [25.5](/filings/0001493152-26-016778.md) | [23.6](/filings/0001641172-25-024207.md) | [23.8](/filings/0001641172-25-024215.md) | [6.7](/filings/0001493152-25-021644.md) | [9.0](/filings/0001493152-26-036606.md) | [9.0](/filings/0001493152-26-023748.md) | [8.1](/filings/0001493152-26-036606.md) |
| Long-term debt | $m | [14.5](/filings/0001493152-23-041096.md) | [55.6](/filings/0001641172-25-003608.md) | [58.2](/filings/0001493152-24-018878.md) | [55.0](/filings/0001493152-24-032185.md) | [54.8](/filings/0001493152-24-044750.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [27.0](/filings/0001493152-24-044750.md) | [34.4](/filings/0001493152-26-016778.md) | [37.0](/filings/0001641172-25-024215.md) | [38.5](/filings/0001493152-25-021644.md) | [39.4](/filings/0001493152-25-021644.md) | [(12.3)](/filings/0001493152-26-036606.md) | [(16.9)](/filings/0001493152-26-036606.md) | [(17.9)](/filings/0001493152-26-036606.md) | [7.0](/filings/0001493152-25-021644.md) | [8.2](/filings/0001493152-26-036606.md) | [6.7](/filings/0001493152-26-036606.md) | [6.1](/filings/0001493152-26-036606.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [740 d](/filings/0001493152-24-044750.md) | [(607) d](/filings/0001641172-25-003608.md) | [1,475](/filings/0001641172-25-024207.md) | [1,230 d](/filings/0001641172-25-024215.md) | [502 d](/filings/0001493152-25-021644.md) | [(2,777) d](/filings/0001493152-26-016778.md) | [(1,141)](/filings/0001493152-26-023748.md) | [(675) d](/filings/0001493152-26-036606.md) | [(538) d](/filings/0001493152-25-021644.md) | [(1,064) d](/filings/0001493152-26-016778.md) | [(1,079)](/filings/0001493152-26-023748.md) | [(1,755) d](/filings/0001493152-26-036606.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001493152-24-044750.md) | [0.0 d](/filings/0001641172-25-003608.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.8](/filings/0001493152-23-041096.md) | [25.7](/filings/0001493152-24-018878.md) | [43.9](/filings/0001493152-24-032185.md) | [49.3](/filings/0001493152-24-044750.md) | [2.8](/filings/0001641172-25-024207.md) | [2.8](/filings/0001641172-25-024215.md) | [2.8](/filings/0001493152-25-021644.md) | [2.8](/filings/0001493152-26-023748.md) | [2.8](/filings/0001493152-26-036606.md) | [3.1](/filings/0001493152-25-021644.md) | [4.4](/filings/0001493152-26-023748.md) | [6.9](/filings/0001493152-26-036606.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,332,955 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001493152-26-036606.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.